Trial Profile
A Multicenter, Randomized, Double-Blinded, Monotherapy-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of the Acarbose and Metformin in Loose-Dose Combination Compared to Metformin Monotherapy in Subjects WithType 2 Diabetic Mellitus (T2DM) That is Inadequately Controlled by Metformin Monotherapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Acarbose/metformin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Bayer
- 20 Aug 2019 Status changed from active, no longer recruiting to completed.
- 24 Apr 2019 Planned End Date changed from 11 Sep 2019 to 12 Aug 2019.
- 24 Apr 2019 Planned primary completion date changed from 11 Sep 2019 to 12 Aug 2019.